Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

August 01, 1989; Volume 250,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Acad, B A

    1. You have access
      Regional O2 consumption and coronary flow during beta adrenoceptor stimulation in reperfused canine myocardium.
      B A Acad and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 611-616;
  2. Amrick, C L

    1. You have access
      Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;
  3. Anderson, D

    1. You have access
      Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.
      M McKinney, D Anderson, C Forray and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 565-572;
  4. Antonelli, T

    1. You have access
      Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;

B

  1. Bäärnhielm, C

    1. You have access
      Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
      S X Wang, T A Sutfin, C Bäärnhielm and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 632-636;
  2. Balduini, W

    1. You have access
      Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development.
      W Balduini and L G Costa
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 541-547;
  3. Barnett, A

    1. You have access
      SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;
  4. Beani, L

    1. You have access
      Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;
  5. Bennett, D A

    1. You have access
      Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;
  6. Bernard, P S

    1. You have access
      Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;
  7. Besseghir, K

    1. You have access
      Transport of methotrexate by the in vitro isolated rabbit proximal tubule.
      K Besseghir, D Mosig and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 688-695;
  8. Bianchi, C

    1. You have access
      Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;
  9. Bigelow, G E

    1. You have access
      Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 485-491;
  10. Bonanno, G

    1. You have access
      Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors.
      M Raiteri, G Bonanno and E Fedele
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 648-653;
  11. Bousquet, P

    1. You have access
      Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
      E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;
  12. Brown, K E

    1. You have access
      An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
      R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;

C

  1. Chiba, S

    1. You have access
      Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
      A Horiuchi, K Iwatsuki, H Yonekura and S Chiba
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 734-739;
  2. Chiorazzi, N

    1. You have access
      Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;
  3. Chiu, P J

    1. You have access
      SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;
  4. Cho, A K

    1. You have access
      Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
      R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;
  5. Choi, D W

    1. You have access
      Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture.
      D M Hartley and D W Choi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 752-758;
  6. Clay, K L

    1. You have access
      Role of brain tyrosine availability in mediating differences in ethanol sensitivity in long-sleep and short-sleep mice.
      T A French, K L Clay and N Weiner
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 556-564;
  7. Costa, L G

    1. You have access
      Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development.
      W Balduini and L G Costa
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 541-547;
  8. Croxson, T S

    1. You have access
      Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;

D

  1. Daly, R N

    1. You have access
      Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
      J P Hieble, J G Duesler and R N Daly
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 523-528;
  2. Derse, C P

    1. You have access
      An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
      R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;
  3. Descatoire, V

    1. You have access
      Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;
  4. Dewar, K M

    1. You have access
      Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
      K M Dewar, B Montreuil, L Grondin and T A Reader
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 696-706;
  5. Donati, D

    1. You have access
      Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis.
      K G Mugridge, D Donati, S Silvestri and L Parente
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 714-720;
  6. Drapeau, G

    1. You have access
      Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;
  7. Drewett, J G

    1. You have access
      Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler, G R Marchand and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 428-432;
  8. Duesler, J G

    1. You have access
      Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
      J P Hieble, J G Duesler and R N Daly
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 523-528;
  9. Duncia, J V

    1. You have access
      Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
      P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;

E

  1. Eberle, N B

    1. You have access
      A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;
  2. el-Fakahany, E E

    1. You have access
      Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.
      M McKinney, D Anderson, C Forray and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 565-572;
  3. Endou, M

    1. You have access
      Differential effects of somatostatin on atrial and ventricular contractile responses in guinea pig heart: influence of pretreatment with islet-activating protein.
      M Endou, Y Hattori, H Nakaya and M Kanno
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 726-733;

F

  1. Fedele, E

    1. You have access
      Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors.
      M Raiteri, G Bonanno and E Fedele
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 648-653;
  2. Feldman, J

    1. You have access
      Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
      E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;
  3. Flynn, D D

    1. You have access
      Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
      D D Flynn and D C Mash
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 573-581;
  4. Forray, C

    1. You have access
      Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.
      M McKinney, D Anderson, C Forray and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 565-572;
  5. Foster, C J

    1. You have access
      SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;
  6. Freeland, H S

    1. You have access
      An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
      R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;
  7. French, T A

    1. You have access
      Role of brain tyrosine availability in mediating differences in ethanol sensitivity in long-sleep and short-sleep mice.
      T A French, K L Clay and N Weiner
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 556-564;
  8. Frenken, M

    1. You have access
      Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system.
      M Frenken and A J Kaumann
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 707-713;

G

  1. George, R

    1. You have access
      Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
      R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;
  2. Gertner, S B

    1. You have access
      Studies on the cardiovascular actions of central histamine H1 and H2 receptors.
      J J Poulakos and S B Gertner
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 500-507;
  3. Ghali, V

    1. You have access
      Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;
  4. Glick, S D

    1. You have access
      A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;
  5. Gogas, K R

    1. You have access
      A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;
  6. Gonon, F

    1. You have access
      Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
      E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;
  7. Grøn, P

    1. You have access
      Skeletal muscle Na,K-pump concentration in children and its relationship to cardiac glycoside distribution.
      K Kjeldsen and P Grøn
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 721-725;
  8. Grondin, L

    1. You have access
      Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
      K M Dewar, B Montreuil, L Grondin and T A Reader
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 696-706;

H

  1. Harf, A

    1. You have access
      Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig.
      I Macquin-Mavier, M Levame, N Istin and A Harf
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 740-745;
  2. Hartley, D M

    1. You have access
      Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture.
      D M Hartley and D W Choi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 752-758;
  3. Haslanger, M F

    1. You have access
      SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;
  4. Hattori, Y

    1. You have access
      Differential effects of somatostatin on atrial and ventricular contractile responses in guinea pig heart: influence of pretreatment with islet-activating protein.
      M Endou, Y Hattori, H Nakaya and M Kanno
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 726-733;
  5. Hay, D W

    1. You have access
      Cellular mechanisms of endothelin in rabbit aorta.
      E H Ohlstein, S Horohonich and D W Hay
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 548-555;
  6. Heishman, S J

    1. You have access
      Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 485-491;
  7. Hieble, J P

    1. You have access
      Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
      J P Hieble, J G Duesler and R N Daly
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 523-528;
  8. Hiramatsu, M

    1. You have access
      Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
      R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;
  9. Ho, B Y

    1. You have access
      Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
      B Y Ho and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 508-514;
  10. Holycross, B J

    1. You have access
      Adenosine-angiotensin II interactions. Part I. Role of adenosine in regulating angiotensin II-induced potentiation of noradrenergic neurotransmission and angiotensin II-induced vasoconstriction.
      B J Holycross and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 433-441;
    2. You have access
      Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
      B J Holycross, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 442-453;
  11. Horiuchi, A

    1. You have access
      Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
      A Horiuchi, K Iwatsuki, H Yonekura and S Chiba
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 734-739;
  12. Horohonich, S

    1. You have access
      Cellular mechanisms of endothelin in rabbit aorta.
      E H Ohlstein, S Horohonich and D W Hay
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 548-555;
  13. Hough, L B

    1. You have access
      A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;
  14. Hutchison, A J

    1. You have access
      Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;

I

  1. Istin, N

    1. You have access
      Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig.
      I Macquin-Mavier, M Levame, N Istin and A Harf
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 740-745;
  2. Itoh, T

    1. You have access
      Additive diuretic effect of S-8666 during furosemide-induced diuresis in rats.
      T Shimizu, T Itoh and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 659-666;
    2. You have access
      Hepatoprotective effects of cystathionine against acetaminophen-induced necrosis.
      Y Kitamura, Y Kamisaki and T Itoh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 667-671;
  3. Iwatsuki, K

    1. You have access
      Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
      A Horiuchi, K Iwatsuki, H Yonekura and S Chiba
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 734-739;

J

  1. Jackson, E K

    1. You have access
      Adenosine-angiotensin II interactions. Part I. Role of adenosine in regulating angiotensin II-induced potentiation of noradrenergic neurotransmission and angiotensin II-induced vasoconstriction.
      B J Holycross and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 433-441;
    2. You have access
      Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
      B J Holycross, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 442-453;
  2. Jones, A W

    1. You have access
      BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
      J M Post, J M Smith and A W Jones
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 591-597;

K

  1. Kalsner, S

    1. You have access
      Nonneurogenic relaxation to field stimulation in coronary arteries.
      S Kalsner and M Quillan
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 461-469;
  2. Kamisaki, Y

    1. You have access
      Hepatoprotective effects of cystathionine against acetaminophen-induced necrosis.
      Y Kitamura, Y Kamisaki and T Itoh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 667-671;
  3. Kanno, M

    1. You have access
      Differential effects of somatostatin on atrial and ventricular contractile responses in guinea pig heart: influence of pretreatment with islet-activating protein.
      M Endou, Y Hattori, H Nakaya and M Kanno
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 726-733;
  4. Kaumann, A J

    1. You have access
      Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system.
      M Frenken and A J Kaumann
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 707-713;
  5. King, A G

    1. You have access
      Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation.
      A G King, K S Landreth and D Wierda
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 582-590;
  6. Kitamura, Y

    1. You have access
      Hepatoprotective effects of cystathionine against acetaminophen-induced necrosis.
      Y Kitamura, Y Kamisaki and T Itoh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 667-671;
  7. Kjeldsen, K

    1. You have access
      Skeletal muscle Na,K-pump concentration in children and its relationship to cardiac glycoside distribution.
      K Kjeldsen and P Grøn
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 721-725;
  8. Kreek, M J

    1. You have access
      Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;
  9. Kurtzman, N A

    1. You have access
      Vanadate stimulates the N-ethylmaleimide-sensitive adenosine triphosphatase in rat nephron.
      S Sabatini and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 529-533;

L

  1. Labbe, G

    1. You have access
      Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;
  2. Landreth, K S

    1. You have access
      Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation.
      A G King, K S Landreth and D Wierda
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 582-590;
  3. Larrey, D

    1. You have access
      Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;
  4. Leighton, H J

    1. You have access
      Analysis of the presence of postjunctional alpha-2 adrenoceptors in the rat anococcygeus muscle.
      M V Ramagopal and H J Leighton
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 492-499;
  5. Lemasters, J J

    1. You have access
      Role of purines and xanthine oxidase in reperfusion injury in perfused rat liver.
      Z Zhong, J J Lemasters and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 470-475;
  6. Letteron, P

    1. You have access
      Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;
  7. Levame, M

    1. You have access
      Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig.
      I Macquin-Mavier, M Levame, N Istin and A Harf
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 740-745;
  8. Li, P

    1. You have access
      Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
      B J Holycross, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 442-453;
  9. Liebman, J M

    1. You have access
      Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;
  10. Liebson, I A

    1. You have access
      Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 485-491;
  11. Loeper, J

    1. You have access
      Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;
  12. Lyon, R A

    1. You have access
      A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;

M

  1. Macquin-Mavier, I

    1. You have access
      Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig.
      I Macquin-Mavier, M Levame, N Istin and A Harf
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 740-745;
  2. Maggi, C A

    1. You have access
      Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;
  3. Marchand, G R

    1. You have access
      Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler, G R Marchand and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 428-432;
  4. Mash, D C

    1. You have access
      Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
      D D Flynn and D C Mash
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 573-581;
  5. McKinney, M

    1. You have access
      Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.
      M McKinney, D Anderson, C Forray and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 565-572;
  6. Meli, A

    1. You have access
      Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;
  7. Mercer, W D

    1. You have access
      Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;
  8. Mermet, C

    1. You have access
      Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
      E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;
  9. Miyata, K

    1. You have access
      Effect of S-8666 on urinary Ca++ excretion in rats.
      T Shimizu, K Miyata and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 654-658;
  10. Montreuil, B

    1. You have access
      Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
      K M Dewar, B Montreuil, L Grondin and T A Reader
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 696-706;
  11. Mosig, D

    1. You have access
      Transport of methotrexate by the in vitro isolated rabbit proximal tubule.
      K Besseghir, D Mosig and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 688-695;
  12. Mugridge, K G

    1. You have access
      Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis.
      K G Mugridge, D Donati, S Silvestri and L Parente
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 714-720;

N

  1. Nakamura, M

    1. You have access
      Effect of S-8666 on urinary Ca++ excretion in rats.
      T Shimizu, K Miyata and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 654-658;
    2. You have access
      Additive diuretic effect of S-8666 during furosemide-induced diuresis in rats.
      T Shimizu, T Itoh and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 659-666;
  2. Nakaya, H

    1. You have access
      Differential effects of somatostatin on atrial and ventricular contractile responses in guinea pig heart: influence of pretreatment with islet-activating protein.
      M Endou, Y Hattori, H Nakaya and M Kanno
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 726-733;
  3. Novick, D M

    1. You have access
      Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;

O

  1. Ochshorn, M

    1. You have access
      Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;
  2. Ohlstein, E H

    1. You have access
      Cellular mechanisms of endothelin in rabbit aorta.
      E H Ohlstein, S Horohonich and D W Hay
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 548-555;

P

  1. Parente, L

    1. You have access
      Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis.
      K G Mugridge, D Donati, S Silvestri and L Parente
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 714-720;
  2. Parini, A

    1. You have access
      Adrenergic agonists and the Na+-K+-adenosine triphosphatase from rabbit proximal tubules and their basolateral membranes.
      R A Podevin and A Parini
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 672-677;
  3. Parsons, M E

    1. You have access
      A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;
  4. Patacchini, R

    1. You have access
      Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;
  5. Pechnick, R N

    1. You have access
      Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
      R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;
  6. Pessayre, D

    1. You have access
      Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;
  7. Peters, S P

    1. You have access
      An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
      R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;
  8. Pitts, B

    1. You have access
      SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;
  9. Podevin, R A

    1. You have access
      Adrenergic agonists and the Na+-K+-adenosine triphosphatase from rabbit proximal tubules and their basolateral membranes.
      R A Podevin and A Parini
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 672-677;
  10. Poland, R E

    1. You have access
      Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
      R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;
  11. Post, J M

    1. You have access
      BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
      J M Post, J M Smith and A W Jones
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 591-597;
  12. Poulakos, J J

    1. You have access
      Studies on the cardiovascular actions of central histamine H1 and H2 receptors.
      J J Poulakos and S B Gertner
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 500-507;
  13. Price, W A

    1. You have access
      Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
      P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;

Q

  1. Quillan, M

    1. You have access
      Nonneurogenic relaxation to field stimulation in coronary arteries.
      S Kalsner and M Quillan
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 461-469;

R

  1. Raiteri, M

    1. You have access
      Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors.
      M Raiteri, G Bonanno and E Fedele
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 648-653;
  2. Ramagopal, M V

    1. You have access
      Analysis of the presence of postjunctional alpha-2 adrenoceptors in the rat anococcygeus muscle.
      M V Ramagopal and H J Leighton
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 492-499;
  3. Reader, T A

    1. You have access
      Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
      K M Dewar, B Montreuil, L Grondin and T A Reader
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 696-706;
  4. Regårdh, C G

    1. You have access
      Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
      S X Wang, T A Sutfin, C Bäärnhielm and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 632-636;
  5. Regoli, D

    1. You have access
      Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;
  6. Reilly, T M

    1. You have access
      Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
      P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;
  7. Roch-Ramel, F

    1. You have access
      Transport of methotrexate by the in vitro isolated rabbit proximal tubule.
      K Besseghir, D Mosig and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 688-695;
  8. Rovero, P

    1. You have access
      Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;

S

  1. Sabatini, S

    1. You have access
      Vanadate stimulates the N-ethylmaleimide-sensitive adenosine triphosphatase in rat nephron.
      S Sabatini and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 529-533;
  2. Schleimer, R P

    1. You have access
      An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
      R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;
  3. Shimizu, T

    1. You have access
      Effect of S-8666 on urinary Ca++ excretion in rats.
      T Shimizu, K Miyata and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 654-658;
    2. You have access
      Additive diuretic effect of S-8666 during furosemide-induced diuresis in rats.
      T Shimizu, T Itoh and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 659-666;
  4. Silvestri, S

    1. You have access
      Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis.
      K G Mugridge, D Donati, S Silvestri and L Parente
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 714-720;
  5. Simonato, M

    1. You have access
      Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;
  6. Smith, J M

    1. You have access
      BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
      J M Post, J M Smith and A W Jones
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 591-597;
  7. Spalluto, P

    1. You have access
      Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;
  8. Stitzer, M L

    1. You have access
      Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 485-491;
  9. Sutfin, T A

    1. You have access
      Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
      S X Wang, T A Sutfin, C Bäärnhielm and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 632-636;
  10. Sybertz, E J

    1. You have access
      SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

T

  1. Takemori, A E

    1. You have access
      Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
      B Y Ho and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 508-514;
  2. Tanganelli, S

    1. You have access
      Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;
  3. Thurman, R G

    1. You have access
      Role of purines and xanthine oxidase in reperfusion injury in perfused rat liver.
      Z Zhong, J J Lemasters and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 470-475;
  4. Tibirica, E

    1. You have access
      Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
      E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;
  5. Timmermans, P B

    1. You have access
      Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
      P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;
  6. Tinel, M

    1. You have access
      Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;
  7. Tomasini, C

    1. You have access
      Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;
  8. Trachte, G J

    1. You have access
      Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler, G R Marchand and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 428-432;

V

  1. Vemulapalli, S

    1. You have access
      SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

W

  1. Wang, S X

    1. You have access
      Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
      S X Wang, T A Sutfin, C Bäärnhielm and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 632-636;
  2. Ward, S J

    1. You have access
      A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;
  3. Watkins, J B

    1. You have access
      Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
      J B Watkins
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 421-427;
  4. Watkins, R W

    1. You have access
      SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;
  5. Weiler, M H

    1. You have access
      Muscarinic modulation of endogenous acetylcholine release in rat neostriatal slices.
      M H Weiler
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 617-623;
  6. Weiner, N

    1. You have access
      Role of brain tyrosine availability in mediating differences in ethanol sensitivity in long-sleep and short-sleep mice.
      T A French, K L Clay and N Weiner
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 556-564;
  7. Weiss, H R

    1. You have access
      Regional O2 consumption and coronary flow during beta adrenoceptor stimulation in reperfused canine myocardium.
      B A Acad and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 611-616;
  8. Wierda, D

    1. You have access
      Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation.
      A G King, K S Landreth and D Wierda
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 582-590;
  9. Wilson, D E

    1. You have access
      Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;
  10. Wong, P C

    1. You have access
      Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
      P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;

Y

  1. Yonekura, H

    1. You have access
      Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
      A Horiuchi, K Iwatsuki, H Yonekura and S Chiba
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 734-739;
  2. Yoshioka, M

    1. You have access
      Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
      M Yoshioka
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 637-641;
  3. Young, R C

    1. You have access
      A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;

Z

  1. Zhong, Z

    1. You have access
      Role of purines and xanthine oxidase in reperfusion injury in perfused rat liver.
      Z Zhong, J J Lemasters and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 470-475;
  2. Ziegler, R J

    1. You have access
      Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler, G R Marchand and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 428-432;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 250, Issue 2
1 Aug 1989
  • Table of Contents
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Smoking Could Worsen COVID-19 Outcome
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Potential Clinical Uses of CBG
  • Nose-to-Brain Delivery
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics